Platelet receptor HPA-1 polymorphism of αIIbβ3 and 807 C/T polymorphism of α2β1 and Buerger's disease

Angiology

Volumn 58, Issue 2, 2007, Pages 169-174

  Ostojic, L ^a,c   Zelenika, D ^a   Zotz, R B ^b   Sucker, C ^b   Ostojic, Z ^a   Loncar, R ^b  

^a University Clinic Mostar   (Bosnia and Herzegovina)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF MOSTAR   (Bosnia and Herzegovina)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BUERGER DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; HUMAN PLATELET ANTIGEN 1 GENE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; SEX RATIO; STATISTICAL SIGNIFICANCE;

ADULT; ANTIGENS, HUMAN PLATELET; CASE-CONTROL STUDIES; GENOTYPE; HUMANS; INTEGRIN ALPHA2BETA1; MALE; PILOT PROJECTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOANGIITIS OBLITERANS;

EID: 34247608901     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707300352     Document Type: Article

References (29)

1. Olin JW: Thromboangiitis obliterans (Buerger's disease). N Engl J Med 343: 864-869, 2000.
2. Mills JL: Buerger's disease in the 21st century: Diagnosis, clinical features and therapy. Semin Vasc Surg 16: 179-189, 2003.
3. Mills JL, Porter JM: Buerger's disease, a review and update. Semin Vasc Surg 6: 14-23, 1993.
4. Mills JL, Porter JM: Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg 5: 570-572, 1991.
5. Adar R., Papa M., Halpern Z.,, et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 308: 1113-1116, 1983.
6. Eichhorn J., Sima D., Lindschau C.,, et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 315: 17-23, 1998.
7. Makita S., Nakamura M., Murakami H.,, et al. Impaired endothelium dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 94 (suppl II). 211-215, 1996.
8. Polanowska-Grabowska R., Simon CG, Gear AR: Platelet adhesion to collagen type I, collagen type IV, von W illebrand factor, fibronectin, laminin and fibrinogen: Rapid kinetics under shear. Thromb Haemost 81: 118-123, 1999.
9. Bini A., Kudryk BJ: Fibrinogen in human atherosclerosis. Ann NY Acad Sci 748: 461-471, 1995.
10. Malek AM, Alper SL, Izumo S.: Hemodynamic shear stress and its role in atherosclerosis. JAMA 282: 2035-2042, 1999.
11. Gawaz M., Neumann FJ, Schömig A.: Evaluation of platelet membrane glycoproteins in coronary artery disease. Circulation 99: E1 - E11, 1999.
12. Ruggeri ZM: Platelets in atherothrombosis. Nat Med 8: 1227-1234, 2002.
13. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95: 1517-1532, 2000.
14. W eiss EJ, Bray PF, Tayback M.,, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334: 1090-1094, 1996.
15. Ridker PM, Hennekens CH, Schmitz C.,, et al. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349: 385-388, 1997.
16. Reiner AP, Kumar PN, Schwartz SM,, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31: 1628-1633, 2000.
17. Unkelbach K., Kalb R., Santoso S.,, et al. Genomic RFLP typing of human platelet alloantigens Zw(PlA), Ko, Bak and Br (HPA-1, 2, 3, 5). Br J Haematol 89: 169-176, 1995.
18. Corral J., Rivera J., Gonzalez-Conejero R.,, et al. The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 39: 372-378, 1999.
19. Brodmann M., Renner W., Stark G.,, et al. Prothrombotic risk factors in patients with thromboangiitis obliterans. Thromb Res 99: 483-486, 2000.
20. Avcu F., Demirkilic U., Yilmaz E.,, et al. The role of pro-thrombotic mutations in patients with Buerger's disease. Thromb Res 100: 143-147, 2000.
21. Avcu F., Akar N., Akar E.,, et al. Prothrombin gene 20210 GA and factor V Arg 506 to Gln mutation in patient with Buerger's disease. J Vasc Dis 51: 421-423, 2000.
22. Zotz RB, Winkelmann Br, Nauck M.,, et al. Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79: 731-735, 1998.
23. Loncar R., Stoldt V., Hellmig S.,, et al. The HPA-1 receptor polymorphism of αIIbβ3 can modulate platelet adhesion onto immobilized fibrinogen under arterial flow conditions. Blood 102: 783a - 784a, 2003.
24. Loncar R., Stoldt V., Thomas V.,, et al. The 807 C/T polymorphism in the α-subunit of integrin α2β1 modulates platelet adhesion onto immobilized collagen under arterial flow conditions. Transfus Med Hemother 31 (suppl 3). 12, 2004.
25. Vijayan KV, Goldschmidt-Clermont PJ, Roos C.,, et al. The P1A2 polymorphism of integrin β3 enhances outside-in signaling and adhesive functions. J Clin Invest 105: 793-802, 2000.
26. Rost M., Sixma JJ, W u Ya-Ping,, et al. Platelet adhesion to collagen in healthy volunteers is influenced by variation of both density and von W illebrand factor. Blood 96: 1433-1437, 2000.
27. Williams Ms, Bray PF: Genetics of arterial prothrombotic risk states. Exp Biol Med 226: 409-419, 2001.
28. Moshfegh K., W uillemin W A., Redondo M.,, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/Iia receptor with risk of myocardial infarction: A case-control study. Lancet 353: 351-354, 1999.
29. Croft SA, Hampton KK, Sorrel JA,, et al. The GPIa C807T dimorphism associated with platelet collagen receptor density is not risk factor for myocardial infarction. Br J Haematol 106: 771-776, 1999.